It's amazing that you attack me for being a short for simply stating that today's pr was irrelevant for the stock price or success of Zalviso when you dominate the threads on this board as someone who just wants to pump the stock. I prefer to just discuss things as they are. I've never shorted a stock in my life and am heavily invested in here. I would advise that you check yourself, however, because as much as you despise those who short because of their constant bashing, you try to prevent only one side, also. Try to be an educator of the company instead of pumping all the time.
C'mon, Adam. A stupid comment? Anybody who follows this company knows that the drug works very well. The drug will be a huge success if approved because of it's effectiveness and ease of use. It's not about the effectiveness, however, and that is why I am saying that today's news is not a surprise to anyone who is familiar with past results of Zalviso. I am uncomfortably deep and in the red here and have held solid for about 20 months now. Nobody wants this to go above $8 more than I, believe me.
Let's be honest, the drug works and works very well. ACRX 04 will be approved as as a result of how it is administered. The only hang up we have here is jumping through more hoops to satisfy FDA requests. News of successful trials is really nothing as the issue is not how well the drug works.